LRP5: a Potential Therapeutic Target in Triple-negative Breast Cancer

被引：0
|
作者：
Maubant, S. [1 ]
Maire, V. [1 ]
Tesson, B. [1 ]
Gentien, D. [1 ]
Marty-Prouvose, B. [1 ]
Cruzalegui, F. [2 ]
Depil, S. [2 ]
Tucker, G. C. [2 ]
Roman-Roman, S. [1 ]
Dubois, T. [1 ]
机构：
[1] Inst Curie, Translat Res Dept, Paris, France
[2] Inst Rech Servier, Oncol Res & Dev Unit, Croissy Sur Seine, France
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72321-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
524
引用
收藏
页码：161 / 162
页数：2
相关论文
共 50 条
  • [41] Chk1 as a new therapeutic target in triple-negative breast cancer
    Albiges, Laurence
    Goubar, Aicha
    Scott, Veronique
    Vicier, Cecile
    Lefebvre, Celine
    Alsafadi, Samar
    Commo, Frederic
    Saghatchian, Mahasti
    Lazar, Vladimir
    Dessen, Philippe
    Delaloge, Suzette
    Andre, Fabrice
    Quidville, Virginie
    [J]. BREAST, 2014, 23 (03): : 250 - 258
  • [42] CDC20 is a novel therapeutic target in triple-negative breast cancer
    Sharma, Jayesh K.
    Alluri, Prasanna
    Udden, Nashir
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [43] Identification of BBOX1 as a therapeutic target in triple-negative breast cancer
    Liao, Chengheng
    Zhang, Yang
    Fan, Cheng
    Herring, Laura E.
    Liu, Juan
    Locasale, Jason W.
    Takada, Mamoru
    Zhou, Jin
    Zurlo, Giada
    Hu, Lianxin
    Simon, Jeremy M.
    Ptacek, Travis S.
    Andrianov, Victor G.
    Loza, Einars
    Peng, Yan
    Yang, Huanghe
    Perou, Charles M.
    Zhang, Qing
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [44] PIM1 MAY BE A THERAPEUTIC TARGET IN TRIPLE-NEGATIVE BREAST CANCER
    不详
    [J]. CANCER DISCOVERY, 2016, 6 (12) : 1303 - 1303
  • [45] SIGNIFICANCE OF C-MET AS A THERAPEUTIC TARGET IN TRIPLE-NEGATIVE BREAST CANCER
    Kashiwagi, S.
    Yashiro, M.
    Aomatsu, N.
    Kawajiri, H.
    Takashima, T.
    Onoda, N.
    Ishikawa, T.
    Hirakawa, K.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 84 - 84
  • [46] Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
    Liao, Chengheng
    Zhang, Yang
    Fan, Cheng
    Herring, Laura E.
    Liu, Juan
    Locasale, Jason W.
    Takada, Mamoru
    Zhou, Jin
    Zurlo, Giada
    Hu, Lianxin
    Simon, Jeremy M.
    Ptacek, Travis S.
    Andrianov, Victor G.
    Loza, Einars
    Peng, Yan
    Yang, Huanghe
    Perou, Charles M.
    Zhang, Qing
    [J]. CANCER DISCOVERY, 2020, 10 (11) : 1706 - 1721
  • [47] Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker
    O'Conor, Christopher J.
    Chen, Tiffany
    Gonzalez, Ivan
    Cao, Dengfeng
    Peng, Yan
    [J]. BIOMARKERS IN MEDICINE, 2018, 12 (07) : 813 - 820
  • [48] CD74: a potential novel target for triple-negative breast cancer
    Tian, Buxian
    Zhang, Yuhong
    Li, Nan
    Liu, Xuewen
    Dong, Jianfeng
    [J]. TUMOR BIOLOGY, 2012, 33 (06) : 2273 - 2277
  • [49] SEPT3 as a Potential Molecular Target of Triple-Negative Breast Cancer
    Yang, Li-Hua
    Wang, Guo-Zhou
    Gao, Chao
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 1605 - 1613
  • [50] PARP1 in triple-negative breast cancer: Expression and therapeutic potential
    Cotter, M. B.
    Pierce, A.
    McGowan, P. M.
    Madden, S. F.
    Flanagan, L.
    Quinn, C.
    Evoy, D.
    Crown, J.
    McDermott, E.
    Duffy, M. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345